APA

Hanin G., Yayon N., Tzur Y., Haviv R., Bennett E. R., Udi S., Krishnamoorthy Y. R., Kotsiliti E., Zangen R., Efron B., Tam J., Pappo O., Shteyer E., Pikarsky E., Heikenwalder M., Greenberg D. S. & Soreq H. (20180727). miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression. : Gut.

Chicago

Hanin Geula, Yayon Nadav, Tzur Yonat, Haviv Rotem, Bennett Estelle R, Udi Shiran, Krishnamoorthy Yoganathan R, Kotsiliti Eleni, Zangen Rivka, Efron Ben, Tam Joseph, Pappo Orit, Shteyer Eyal, Pikarsky Eli, Heikenwalder Mathias, Greenberg David S and Soreq Hermona. 20180727. miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression. : Gut.

Harvard

Hanin G., Yayon N., Tzur Y., Haviv R., Bennett E. R., Udi S., Krishnamoorthy Y. R., Kotsiliti E., Zangen R., Efron B., Tam J., Pappo O., Shteyer E., Pikarsky E., Heikenwalder M., Greenberg D. S. and Soreq H. (20180727). miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression. : Gut.

MLA

Hanin Geula, Yayon Nadav, Tzur Yonat, Haviv Rotem, Bennett Estelle R, Udi Shiran, Krishnamoorthy Yoganathan R, Kotsiliti Eleni, Zangen Rivka, Efron Ben, Tam Joseph, Pappo Orit, Shteyer Eyal, Pikarsky Eli, Heikenwalder Mathias, Greenberg David S and Soreq Hermona. miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression. : Gut. 20180727.